Ueda K, Kuwajima I, Murakami M, Yoshida H
Jpn Heart J. 1986 Jan;27(1):55-70. doi: 10.1536/ihj.27.55.
The antihypertensive effect and safety of long-term therapy with nifedipine were evaluated in 132 hypertensive patients, including 100 aged patients who received nifedipine alone or with other antihypertensive agents for a mean duration of 28.6 months. A prompt hypotensive effect was observed 1 month after the initiation of nifedipine therapy. The hypotensive effect persisted for the entire follow-up period and was related to the pretreatment mean blood pressure level. Late drug tolerance was not observed. Dizziness, facial flushing and other unpleasant sensations were observed in 7.5% and ankle edema in 9.8% of the patients. The therapy did not significantly influence serum creatinine levels. Hypotension and side effects were the cause of discontinuation in 10.6% and 4.5% of patients, respectively. We conclude that long-term antihypertensive therapy with nifedipine is both effective and safe, not only in adult patients but also in the high-risk aged patient.
对132例高血压患者评估了硝苯地平长期治疗的降压效果和安全性,其中100例老年患者单独或与其他抗高血压药物联合使用硝苯地平,平均疗程为28.6个月。硝苯地平治疗开始1个月后观察到迅速的降压效果。降压效果在整个随访期持续存在,且与治疗前平均血压水平相关。未观察到后期药物耐受性。7.5%的患者出现头晕、面部潮红和其他不适感觉,9.8%的患者出现踝部水肿。该治疗对血清肌酐水平无显著影响。低血压和副作用分别导致10.6%和4.5%的患者停药。我们得出结论,硝苯地平长期抗高血压治疗不仅对成年患者有效且安全,对高危老年患者也是如此。